NEWS
Panel discussion spotlights COVID-19 R&D
The Data Science Institute's career panel series continued on June 28 with a discussion of LLNL’s COVID-19 research and development. Four data scientists talked about their work in drug screening, protein–drug compounds, antibody–antigen sequence analysis, and risk factor identification.
UC Merced students work with LLNL mentors on potential new drugs to combat COVID-19
For the first time in the DSC series since the COVID-19 pandemic began in 2020, Lab mentors visited the college campus to provide in-person guidance for five teams of UC Merced students.
Assured and robust…or bust
Livermore’s machine learning experts aim to provide assurances on performance and enable trust in machine-learning technology through innovative validation and verification techniques.